Skip to main content
OpenTrials

Clinical trial condition

ANCA-associated Vasculitis

Explore clinical trials studying ANCA-associated Vasculitis. Study availability and eligibility vary by location and protocol.

19 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

ANCA-associated Vasculitis trial results

Active, not recruiting

Avacostar - (PASS)

NCT05897684

Conditions
ANCA-associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +8 more
Locations
  • Charité University Medicine Berlin, Germany
  • University Hospital of Cologne Cologne, Germany
  • Municipal Hospital Dresden Dresden, Germany
  • University Hospital Essen Essen, Germany
View all 35 locations
View Trial Details
Completed

Biosimilars of Rituximab in ANCA-associated Vasculitis Compared to the Originator

NCT05716334

Conditions
ANCA-associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +19 more
Locations
  • University of Calgary Calgary, Alberta, Canada
  • University of Alberta Edmonton, Alberta, Canada
  • University of British Columbia (Vancouver Coastal Health Authority) Vancouver, British Columbia, Canada
  • St Joseph's Healthcare Hamilton (McMaster University) Hamilton, Ontario, Canada
View Trial Details
Completed

Efficacy and Safety of Substitution of Glucocorticoid for BDB-001 Injection in Patients With Anti-neutrophil Cytoplasmic Antibody(ANCA)-Associated Vasculitis

NCT05197842

Conditions
ANCA-associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +8 more
Locations
  • The Second hospital Of Anhui Medical University Hefei, Anhui, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Peking University First Hospital Beijing, Beijing Municipality, China
  • Peking University International Hospital Beijing, Beijing Municipality, China
View all 22 locations
View Trial Details
Completed

A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis

NCT02994927

Conditions
ANCA-associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +8 more
Locations
  • Clinical Trial Site Huntsville, Alabama, United States
  • Clinical Trial Site Phoenix, Arizona, United States
  • Clinical Trial Site Phoenix, Arizona, United States
  • Clinical Trial Site Los Angeles, California, United States
View all 198 locations
View Trial Details
Completed

Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's)

NCT02108860

Conditions
ANCA-associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +15 more
Locations
  • Cedars Sinai Medical Center, Los Angeles Los Angeles, California, United States
  • University of South Florida Rheumatology Tampa, Florida, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
  • University of Michigan Ann Arbor, Michigan, United States
View all 20 locations
View Trial Details

Related conditions